Janvier Serumondo

456 total citations
25 papers, 199 citations indexed

About

Janvier Serumondo is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, Janvier Serumondo has authored 25 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 22 papers in Hepatology and 2 papers in Physiology. Recurrent topics in Janvier Serumondo's work include Hepatitis B Virus Studies (22 papers), Hepatitis C virus research (22 papers) and Liver Disease Diagnosis and Treatment (13 papers). Janvier Serumondo is often cited by papers focused on Hepatitis B Virus Studies (22 papers), Hepatitis C virus research (22 papers) and Liver Disease Diagnosis and Treatment (13 papers). Janvier Serumondo collaborates with scholars based in Rwanda, United States and Canada. Janvier Serumondo's co-authors include Jean Damascène Makuza, Sabin Nsanzimana, Marie Paul Nisingizwe, Neil Gupta, David J. Riedel, Carol Liu, Soline Dusabeyesu Mugeni, Fredrick Kateera, Fabienne Shumbusho and Claude Mambo Muvunyi and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Janvier Serumondo

23 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janvier Serumondo Rwanda 9 164 153 27 16 12 25 199
Carla Gorton Australia 5 237 1.4× 241 1.6× 47 1.7× 5 0.3× 17 1.4× 9 273
Azuka Patrick Okwuraiwe Nigeria 7 77 0.5× 60 0.4× 53 2.0× 9 0.6× 21 1.8× 23 135
Jess Howell Australia 7 192 1.2× 184 1.2× 21 0.8× 3 0.2× 6 0.5× 17 219
Madeline Adee United States 8 87 0.5× 67 0.4× 22 0.8× 3 0.2× 18 1.5× 14 121
Aurielle Thomas United States 5 179 1.1× 186 1.2× 34 1.3× 3 0.2× 6 0.5× 11 216
Zhongping Duan China 4 420 2.6× 363 2.4× 86 3.2× 6 0.4× 8 0.7× 10 446
Akaki Abutidze Georgia 7 147 0.9× 112 0.7× 53 2.0× 4 0.3× 3 0.3× 28 176
Carlos Eduardo Brandão Brazil 6 100 0.6× 95 0.6× 25 0.9× 2 0.1× 11 0.9× 14 131
K. Kaita Canada 7 148 0.9× 161 1.1× 31 1.1× 2 0.1× 4 0.3× 14 195
V. Baclet France 6 56 0.3× 25 0.2× 43 1.6× 26 1.6× 10 0.8× 12 103

Countries citing papers authored by Janvier Serumondo

Since Specialization
Citations

This map shows the geographic impact of Janvier Serumondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janvier Serumondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janvier Serumondo more than expected).

Fields of papers citing papers by Janvier Serumondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janvier Serumondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janvier Serumondo. The network helps show where Janvier Serumondo may publish in the future.

Co-authorship network of co-authors of Janvier Serumondo

This figure shows the co-authorship network connecting the top 25 collaborators of Janvier Serumondo. A scholar is included among the top collaborators of Janvier Serumondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janvier Serumondo. Janvier Serumondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Makuza, Jean Damascène, Dahn Jeong, Michael R. Law, et al.. (2025). Hepatitis B Virus Care Cascade in Rwanda: A Population-based Study From 2016–2023. Clinical Infectious Diseases. 81(6). 1091–1101.
2.
Serumondo, Janvier, et al.. (2025). Introducing Sofosbuvir/Velpatasvir + Ribavirin as a Generic Retreatment Regimen for Hepatitis C: Evaluation of a Government Program in Rwanda. Clinical Infectious Diseases. 80(6). 1302–1305. 2 indexed citations
3.
4.
Hiebert, Lindsey, et al.. (2024). Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation. Value in Health. 27(7). 918–925. 3 indexed citations
5.
Handanagić, Senad, Shaun Shadaker, Jan Drobeniuc, et al.. (2023). Lessons Learned From Global Hepatitis C Elimination Programs. The Journal of Infectious Diseases. 229(Supplement_3). S334–S341. 11 indexed citations
6.
Nisingizwe, Marie Paul, Jean Damascène Makuza, Naveed Z. Janjua, et al.. (2023). The Cascade of Care for Hepatitis C Treatment in Rwanda: A Retrospective Cohort Study of the 2017–2019 Mass Screening and Treatment Campaign. Viruses. 15(3). 661–661. 5 indexed citations
7.
Gupta, Neil, Fabienne Shumbusho, Janvier Serumondo, et al.. (2022). Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial. ˜The œLancet. Gastroenterology & hepatology. 7(6). 542–551. 15 indexed citations
8.
Makuza, Jean Damascène, Dahn Jeong, Marie Paul Nisingizwe, et al.. (2022). Epidemiology of sexually transmitted infections: trends among patients screened for sexually transmitted infections in rwandan health facilities 2014–2020. BMC Infectious Diseases. 22(1). 701–701. 2 indexed citations
9.
Kateera, Fredrick, Fabienne Shumbusho, Janvier Serumondo, et al.. (2022). Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial. ˜The œLancet. Gastroenterology & hepatology. 7(6). 533–541. 9 indexed citations
10.
Shumbusho, Fabienne, et al.. (2022). Time to complete hepatitis C cascade of care among patients identified during mass screening campaigns in rural Rwanda: a retrospective cohort study. BMC Infectious Diseases. 22(1). 272–272. 6 indexed citations
11.
Barnhart, Dale A., et al.. (2021). Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study. PLoS ONE. 16(10). e0257917–e0257917. 5 indexed citations
12.
Barnhart, Dale A., et al.. (2021). Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach. BMC Infectious Diseases. 21(1). 220–220. 9 indexed citations
13.
Serumondo, Janvier, et al.. (2021). Values and preferences for hepatitis C self-testing among the general population and healthcare workers in Rwanda. BMC Infectious Diseases. 21(1). 1064–1064. 9 indexed citations
14.
Nuil, Jennifer Ilo Van, Grace Umutesi, Fabienne Shumbusho, et al.. (2020). Improved quality of life following direct‐acting antiviral treatment for chronic hepatitis C infection in Rwanda: Results from a clinical trial in sub‐Saharan Africa (the SHARED study). Journal of Viral Hepatitis. 28(1). 112–120. 3 indexed citations
15.
Makuza, Jean Damascène, Marie Paul Nisingizwe, Janvier Serumondo, et al.. (2020). Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study. BMJ Open. 10(7). e036711–e036711. 7 indexed citations
16.
17.
Makuza, Jean Damascène, et al.. (2019). Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda. BMC Infectious Diseases. 19(1). 381–381. 43 indexed citations
18.
Makuza, Jean Damascène, Carol Liu, Marie Paul Nisingizwe, et al.. (2019). Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program. BMC Infectious Diseases. 19(1). 688–688. 23 indexed citations
19.
Muvunyi, Claude Mambo, et al.. (2014). Improving the quality of laboratory systems through Strengthening Laboratory Management Towards Accreditation (SLMTA) in Rwanda, 2010-2013. International Journal of Infectious Diseases. 21. 386–386.
20.
Mazarati, Jean Baptiste, et al.. (2014). Innovative strategies for a successful SLMTA country programme: The Rwanda story. African Journal of Laboratory Medicine. 3(2). 217–217. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Gorton Breakdown of academic impact, for papers by Azuka Patrick Okwuraiwe Breakdown of academic impact, for papers by Jess Howell Breakdown of academic impact, for papers by Madeline Adee Breakdown of academic impact, for papers by Aurielle Thomas Breakdown of academic impact, for papers by Zhongping Duan Breakdown of academic impact, for papers by Akaki Abutidze Breakdown of academic impact, for papers by Carlos Eduardo Brandão Breakdown of academic impact, for papers by K. Kaita Breakdown of academic impact, for papers by V. Baclet
Rankless by CCL
2026